Injective (INJ) is currently trading at $2.93, showing a modest 24-hour change of 2.97%. The daily range has been relatively narrow, with a high of $2.96 and a low of $2.84, indicating limited volatility in the short term.

The trading volume over the last 24 hours stands at approximately $41.7 million, reflecting a Vol/Market Cap ratio of 14.26%, which suggests a healthy level of trading activity relative to its market capitalization. However, the 7-day and 14-day price changes indicate a bearish trend, with declines of 4.65% and 9.93% respectively, highlighting some weakness in investor sentiment.

Moving averages reveal a mixed short-term outlook; while the 8 SMA and 13 SMA are showing upward momentum, the 144 SMA indicates a slight downtrend. The 1-hour RSI of 63 suggests that the asset is approaching overbought territory, while the 7-day RSI at 48 indicates a neutral position, suggesting indecision among traders.

Injective's current price is significantly below its all-time high of $52.62, achieved in March 2024, indicating a potential for recovery if market conditions improve. However, the recent price declines over the past month, with a 30-day price change of -10.17%, could deter new investors from entering the market.

Considering the overall technical indicators and recent price performance, the recommendation for Injective (INJ) is to Hold. The asset shows potential for short-term gains, but the longer-term bearish trends and proximity to overbought conditions warrant caution before making new purchases.